← Back to Search

Behavioural Intervention

Neurolens spectacle lens for Headache

N/A
Waitlist Available
Research Sponsored by Neurolens Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-40 days

Summary

This trial tests special glasses called neurolens on people aged 18-60 with chronic headaches. The glasses use a special prism to reduce eye strain and improve comfort, which may help alleviate headache symptoms.

Eligible Conditions
  • Digital Eye Strain
  • Strabismus
  • Headache
  • Convergence Insufficiency

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-40 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-40 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Headache Impact Test (HIT-6) questionnaire
Secondary study objectives
Patients with reduced near point of convergence (NPC)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: NeurolensExperimental Treatment1 Intervention
Our proprietary contoured prism lens design, commercially known as neurolens.
Group II: Control lensPlacebo Group1 Intervention
A simple refractive error correction lens
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurolens spectacle lens
2021
N/A
~300

Find a Location

Who is running the clinical trial?

Neurolens Inc.Lead Sponsor
2 Previous Clinical Trials
110 Total Patients Enrolled
Corina Van De Pol, OD PhDStudy DirectorNeurolens Inc.
~75 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top